NYT > Health: Glaxo Sales Fall in China as Inquiry Continues

Glaxo Sales Fall in China as Inquiry Continues

The drug giant reported that third-quarter product sales in China, where it faces a continuing bribery investigation, dropped 61 percent as rivals gra...

Source: http://www.nytimes.com/2013/10/24/business/international/glaxosmithkline-earnings-hit-by-slumping-china-sales.html?partner=rss&emc=rss